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1 Summary 
The anaerobic spirochaete Brachyspira (B.) hyodysenteriae is the causative agent of swine 
dysentery (SD), a severe mucohaemorrhagic diarrheal disease in pigs worldwide. Currently, 
no data for antimicrobial susceptibility of B. hyodysenteriae from Switzerland are available 
and though antimicrobial treatment is the main therapy, no standardised methods for 
antimicrobial susceptibility testing are established. Therefore, a broth microdilution test was 
performed for 30 Swiss porcine field isolates and evaluated for its suitability in diagnostics. 
For the pleuromutilins, tiamulin and valnemulin, a good reproducibility in testing and 
susceptibility at low concentrations could be observed. The reproducibility for doxycycline 
was acceptable. A part of the isolates showed reduced susceptibility. For lincomycin and the 
macrolides, tylosin and tylvalosin, reproducibility was influenced by the occurrence of 
so-called skips. Furthermore, reduced susceptibility for lincomycin and resistance for tylosin 
could be detected. Sequencing of the 23S rDNA revealed, that a point mutation is responsible 
for resistance and a possible explanation for the skipped wells. In a European comparison 
Switzerland is still in a favourable situation. However, accurate determination of minimal 
inhibitory concentrations is questionable, and a classification of isolates into susceptible and 
resistant isolates is difficult due to the lack of unambiguous classification criteria. 
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Zusammenfassung 
Die anaerobe Spirochäte Brachyspira (B.) hyodysenteriae ist der ursächliche Erreger der 
Schweinedysenterie (SD), einer weltweit vorkommenden schweren mukohämorrhagischen 
Durchfallerkrankung bei Schweinen. Derzeit gibt es keine Daten aus der Schweiz zur 
Antibiotikaempfindlichkeit von B. hyodysenteriae und obwohl die Behandlung mit 
Antibiotika die wichtigste Therapie ist, sind keine standardisierten Methoden zur 
Empfindlichkeitsprüfung etabliert. Deshalb wurden 30 Schweizer Feldisolate aus dem 
Schwein mittels eines Mikrodilutionstests untersucht und dessen Eignung für die Diagnostik 
evaluiert. Für die Pleuromutiline, Tiamulin und Valnemulin, konnte eine gute 
Reproduzierbarkeit unter der Testung und eine Hemmung bei geringen Konzentrationen 
beobachtet werden. Die Reproduzierbarkeit für Doxycyclin war akzeptabel. Ein Teil der 
Isolate zeigte eine reduzierte Empfindlichkeit. Für Lincomycin und die Makrolide Tylosin 
und Tylvalosin war die Reproduzierbarkeit von sogenannten Skips beeinflusst. Darüber 
hinaus konnte eine reduzierte Empfindlichkeit für Lincomycin und Resistenz bei Tylosin 
entdeckt werden. Die Sequenzierung der 23S rDNS zeigte, dass eine Punktmutation für die 
Resistenz verantwortlich ist. Ausserdem stellt sie eine mögliche Erklärung für die Skips dar. 
Im europäischen Vergleich ist die Situation der Schweiz immer noch günstig. Trotzdem ist 
die akkurate Bestimmung der minimalen Hemmstoffkonzentration fragwürdig und eine 
Klassifizierung der Isolate in sensibel und resistent ist aufgrund des Mangels an eindeutigen 
Klassifizierungskriterien schwierig. 

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2 Introduction
 
2.1 Taxonomy 
The order of Spirochaetales is divided into three families (Brachyspiraceae, Leptospiraceae 
and Spirochaetaceae). The family Brachyspiraceae includes a sole genus, Brachyspira. The 
phylogenetic analysis of Brachyspira is based on 16S rDNA sequencing (Paster, 2011). 
Phylum:  Spirochaetes 
Class:  Spirochaetes 
Order:   Spirochaetales 
Family:  Brachyspiraceae 
Genus:  Brachyspira 
In the last decades many taxonomical reorganisations have been made and, with a large 
amount of non-classified species, they are still ongoing. The most relevant species in 
veterinary medicine is Brachyspira (B.) hyodysenteriae, the agent of swine dysentery. At the 
beginning of the 20th century, a spirochaete was described as the cause of the disease. Later, 
infection trials were made and the new species Treponema hyodysenteriae was regarded as 
the agent of swine dysentery (SD) (Taylor and Alexander, 1971; Glock and Harris, 1972; 
Harris et al., 1972). Initially, Treponema hyodysenteriae was grouped into pathogenic (with 
strong beta-haemolysis) and non-pathogenic (weakly haemolytic) strains until DNA 
comparison revealed a homology of only about 28% (Miao et al., 1978). Subsequently, the 
weakly haemolytic strains were classified in a new apathogenic species Treponema innocens 
(Kinyon and Harris, 1979). The genus name Brachyspira was first used for the spirochaete 
Brachyspira aalborgi, isolated from human intestine (Hovind-Hougen et al., 1982). 
Sequencing of the 16S rDNA in 1991 lead to the establishment of a new genus called Serpula 
including Serpula hyodysenteriae and Serpula innocens (Stanton et al., 1991). According to 
phylogenetic rules, the genus had to be renamed to Serpulina one year later since the name 
Serpula already designated a genus of fungi (Stanton, 1992). Another five years later, 
Serpulina spp. were phylogenetically compared to Brachyspira aalborgi, and the genera of 
Brachyspira and Serpulina were unified (Ochiai et al., 1997). Unfortunately, two new species, 
Serpulina intermedia and Serpulina murdochii were discovered at about the same time 
(Stanton et al., 1997) and subsequently had to be renamed to Brachyspira intermedia and 
Brachyspira murdochii (Hampson and La, 2006). Until now there are seven designated 
species of Brachyspira: Brachyspira (B.) hyodysenteriae, B. pilosicoli (Trott et al., 1996), 
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B. innocens (Kinyon and Harris, 1979), B. intermedia (Stanton et al., 1997), B. murdochii 
(Stanton et al., 1997), B. aalborgi (Hovind-Hougen et al., 1982), and B. alvinipulli (Stanton et 
al., 1998). Additionally, there are more species provisionally designated until today: As 
(potential) pathogens in pigs ‘B. hampsonii’ (Chander et al., 2012; Rubin et al., 2013) and 
‘B. suanatina’ (Råsbäck et al., 2007), which both show a complete beta-haemolysis on blood 
agar, and in a diversity of other animal species and in humans ‘B. christiani’ (Jensen et al., 
2001), ‘B. pulli’ (McLaren et al., 1997; Stephens and Hampson, 1999), ‘B. canis’ (Duhamel et 
al., 1998), ‘B. corvi’ (Jansson et al., 2008b), ‘B. rattus’, ‘B. muris’, ‘B. muridarum’ (Backhans 
et al., 2010). 
 
 
2.2 Morphology 
Spirochaetes, including the genus Brachyspira, are characterised by their unique helical 
ultrastructure, which is built of three major structures: the outer sheath, periplasmic flagella 
and the protoplasmic cylinder. The outer sheath, the outermost layer, is trilaminar and 
surrounds the periplasmic space containing the endoflagella, which enables the spirochaete to 
be motile, and the protoplasmic cylinder (Sellwood and Bland, 1997). The flagella are 
connected with their proximal ends to the cylinder by insertion discs located at both poles of 
the cylinder. The distal ends are free and overlap with the free ends of the endoflagella from 
the opposite cylinder pole in the centre of the cell (Markey et al., 2013). The number of 
flagella varies per species and roughly equal numbers are attached to each end of the cylinder 
(Stanton, 2011). In contrast to most bacterial flagella, which consist of one protein (flagellin), 
the flagella of B. hyodysenteriae is composed of two sheath proteins and three core proteins 
(Koopman et al., 1992a). The protoplasmic cylinder, the main body of the cell, is coiled. It 
consists of the cell wall and the cytoplasmic membrane, which enclose the cytoplasmic 
contents including the nuclear material.  
Brachyspira are from 2 µm to 11 µm long and from 0.2 µm to 0.4 µm in diameter (Stanton, 
2011). Based on the cell size and flagellar number, species can be distinguished. 
B. hyodysenteriae, B. innocens, B. intermedia, B. murdochii, and B. alvinipulli are larger in 
cell size and have 20–30 flagella per cell. In contrast, B. pilosicoli and B. aalborgi have 8–12 
flagella per cell and are shorter. Another criterion for morphological differentiation is the end 
shape of the cells. B. pilosicoli and B. aalborgi have pointed and tapered ends, respectively, 
whereas the remaining species have blunted cell ends (Stanton, 2011). Even though 
spirochaetes are negative in Gram staining and their outer sheath shares features 
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(lipooligosaccharides, which are similar to lipopolysaccharides) with the outer membrane of 
Gram-negative bacteria, they are phylogenetically completely distinct (Sellwood and Bland, 
1997). 
 
2.3 Metabolism 
Brachyspira are anaerobes with a certain aerotolerance, and a culture atmosphere with 1% 
oxygen yielded higher growth rates (Stanton and Lebo, 1988). The core enzyme to reduce 
oxygen is a NADH oxidase (Stanton and Jensen, 1993). The NADH oxidase gene (nox) is 
present in strains throughout the genus (Stanton et al., 1995; Atyeo et al., 1999). The ability to 
handle oxidative stress allows Brachyspira to colonize the large intestine and to have a close 
attachment to host tissue, which represents an ecological advantage over other intestinal 
bacteria (Stanton, 1997). Carbohydrates are an energy source and Brachyspira ferment mono-, 
di- and trisaccharides as well as amino sugars (Stanton, 1997). Specific for B. pilosicoli is the 
degradation of D-ribose and the lack of beta-glycosidase (Fellström and Gunnarsson, 1995). 
For glycolysis, the Embden-Meyerhof-Parnas (EMP) pathway is used (Stanton, 1989). The 
yielded pyruvate is catabolised to acetyl-CoA, H2 and CO2 by the clostridial-type clastic 
reaction. Finally, Acetyl-CoA is degraded to acetate, butyrate or ethanol by a branched 
fermentation pathway. H2 and CO2 are produced in a 2:1 proportion (Stanton, 1989; Stanton, 
1997). Additionally, a non-oxidative pentose phosphate pathway is identified (Bellgard et al., 
2009). B. murdochii and B. pilosicoli encode genes for enzymes of the incomplete 
tricarboxylic acid cycle, which are missing in B. hyodysenteriae. Besides, genes of the glycine 
reductase complex are found in B. murdochii and B. pilosicoli (Wanchantuek et al., 2010). 
Cholesterol (Lemcke and Burrows, 1980) and phospholipids (Stanton, 1987) are essential for 
the growth of B. hyodysenteriae. Cholesterol, for the most part converted to cholestenol, is 
used for membrane synthesis (Stanton, 1987). The capacity for fatty acid and lipid 
biosynthesis exists and beta-oxidation of long-chain fatty acids is possible (Bellgard et al., 
2009). The complete set of genes encoding nucleotide metabolism and lipooligosaccharide 
biosynthesis are present (Bellgard et al., 2009).  
B. hyodysenteriae expresses iron-regulated proteins, and a periplasmic iron import system has 
been described (Li et al., 1995; Dugourd et al., 1999). For the iron acquisition in B. pilosicoli 
the gene for a ferrous transporter has been found (Mappley et al., 2012). 
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2.4 Genomics 
Until now the complete genomes of B. hyodysenteriae, B. pilosicoli, B. murdochii and 
B. intermedia have been sequenced (Bellgard et al., 2009; Pati et al., 2010; Wachanthuek et 
al., 2010; Håfström et al., 2011; Mappley et al., 2012; Lin et al., 2013). Comparative studies 
of protein-coding sequences reveal more matches with other intestinal bacteria like 
Clostridium and Escherichia than with other spirochaetes, reflecting the adaption to their 
common habitat (Bellgard et al., 2009).  
In general, Brachyspira have a singular circular chromosome with an average G+C content of 
about 26%. The genome size differs per species between 2.4 and 3.2 Mbp (Stanton, 1997). 
More specialised species like B. hyodysenteriae and B. pilosicoli underwent a reductive 
genome evolution. Interestingly, different B. pilosicoli strains vary in genome size (Mappley 
et al., 2012). Genome comparison reveals that the swine pathogens B. hyodysenteriae and 
B. pilosicoli share the least number of genes and differ in their genetic organisation (Zuerner 
et al., 2004). They went through different phylogenetic developments in which B. pilosicoli 
separated earlier and is considered the older pathogen (Håfström et al., 2011; Mappley et al., 
2012). Furthermore, a plasmid has been found in B. hyodysenteriae, B. intermedia and 
B. murdochii isolates but not yet in B. pilosicoli (Bellgard et al., 2009; Wachanthuek et al., 
2010; Håfström et al., 2011; Mappley et al., 2012). A bacteriophage was detected and later 
identified and classified as the general transducing bacteriophage VSH-1 in B. hyodysenteriae 
and B. innocens (Humphrey et al., 1995; Humphrey et al., 1997). It is the only known natural 
gene transfer mechanism of B. hyodysenteriae (Stanton, 1997). VSH-1 is inducible by 
mitomycin C, carbadox and metronidazole, and a transmission of chloramphenicol and tylosin 
resistance could be proved in vitro (Stanton et al., 2008). Genomic studies give hints for the 
existence of bacteriophages in B. intermedia, B. pilosicoli and B. murdochii, and 
bacteriophages that are inducible by mitomycin C could be detected in cultures of 
B. pilosicoli (Calderaro et al., 1998a/b; Stanton et al., 2003). Due to genetic transfer 
mechanisms, the genetic population structure of B. hyodysenteriae and B. pilosicoli is 
epidemic (Trott et al., 1998). That means the population appears clonal because of certain 
clonal groups being dominant although recombination occurs (Maynard Smith et al., 1993). In 
general, Brachyspira are genetically diverse, and gene transfer not only occurs within a 
species but also between different species (Humphrey et al., 1995). 
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2.5 Pathogenicity 
The intestinal spirochaete with the greatest veterinary significance is B. hyodysenteriae as the 
agent of SD in pigs. The disease is characterised by mucohaemorrhagic diarrhoea. It is one of 
the most relevant porcine intestinal infections worldwide. Prevalences in Europe differ from 
2.5% to 14% in Denmark, 13% in the United Kingdom, 10.81% in Italy, and 32.1% in Spain 
(M
ller et al., 1998; Stege et al., 2000; Thomson et al., 2001; Merialdi et al., 2003; Carvajal et 
al., 2006). In a Swedish study, B. hyodysenteriae could not be detected in the investigated 
herds even though the disease occurs in the country (Jacobson et al., 2005). In general, 
B. hyodysenteriae is isolated from a broad host spectrum including wildlife and domestic 
animals. Some animal species such as rheas show typhlocolitis with pathological lesions 
which are similar to those found in infected pigs (Sargatz et al., 1992; Jensen et al., 1996). 
Gross lesions were also found in wild mice but pathogenicity remains unclear (Joens and 
Kinyon, 1982). The focus of interest rather lies on the potential of wildlife being a reservoir 
for SD than on the infection in the animals. Especially wild mice and rats (Joens and Kinyon, 
1982; Backhans et al., 2011) and free-living birds (Jansson et al., 2004) are considered to play 
a role in transmission of B. hyodysenteriae between farms as well as in its spreading and 
persisting within a farm. Furthermore, B. hyodysenteriae could be isolated from wild boar in 
Australia, whereas no Brachyspira spp. could be detected in Sweden (Fellström et al., 2002; 
Jacobsen et al., 2005; Phillips et al., 2009). Additionally, insects and indirect transmission 
may have a greater impact on the spreading of disease than originally thought (Blunt and 
McOrist, 2008; Blunt et al., 2010;Alvarez-Ordóñez et al., 2013). B. hyodysenteriae is known 
to survive in faeces up to 112 days at a temperature of 10°C (Boye et al., 2001).  
Within a herd, the agent is transmitted faecally-orally. The outcome of disease is influenced 
by age, stress, production of acid in the stomach, nutrition, infectious dose and virulence 
(Alvarez-Ordóñez et al., 2013). Incubation time is about 14 days. The course varies from 
inapparent or mild to severe with high mortality especially in native herds. In classical cases, 
animals show a slight depression with reduced, but preserved, desire for food. Faeces are 
watery, porridge-like and dark-coloured. With the progression of disease, it contains mucus 
and fresh blood. A typical sign seen in milder courses are tucked-in flanks. Mortality is due to 
reduced food and water partake and a following dehydration. Most animals gradually recover 
within two weeks. Feed conversion often is reduced for the remaining period of production. 
Mainly concerned are weaners and growers in fattening farms. Studies including animals up 
to the finishing period show higher prevalences for SD. The onset of disease might be 
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strongly influenced by the preventive use of antimicrobials and can first occur in the finishing 
period when all medications are removed to avoid antimicrobial residues in meat (Hampson et 
al., 1997). Therefore, an increase of postweaning diarrhoea was reported after the ban of 
growth promoters in Sweden and Europe (Robertsson and Lundeheim, 1994; Stein, 2002). 
Nevertheless, in a Danish study, B. hyodysenteriae could be isolated in equal numbers 
irrespectively of the use of food additives in the farms (Møller et al., 1998). The missing of 
typical symptoms of SD in breeding farms is due to the endemic spread with accompanied 
immunity in sows or, especially in Switzerland, due to the high-health status of breeding 
herds. In a study from Spain, B. hyodysenteriae could be isolated from swine of all ages 
including sows, and all of them showed symptoms of diarrhoea (Carvajal et al., 2006).  
SD is a multifactorial disease, and due to the complexity of different factors, pathogenesis is 
not fully understood (Hampson et al., 2006). Diet, housing and exposure to stress have a 
significant impact on occurrence and course of disease (Jacobsen et al., 2005). Besides, a 
synergistic interaction with other anaerobic bacteria of the intestinal microbiota facilitates 
colonization and development of lesions (Meyer et al., 1974; Whipp et al., 1979). 
Undoubtedly, there is an influence of feeding to expression of SD. Nevertheless, it is still 
controversially discussed because preventive effects of diets are often not reproducible, which 
underlines the multifactorial character of the infection. A diet composed of cooked rice and 
animal protein showed a protective effect (Siba et al., 1996), which was explained with a 
reduced fermentation in the large intestine because of lesser amounts of resistant starch and 
soluble non-starch polysaccharides in the diet (Pluske et al., 1996; Pluske et al., 1998; Durmic 
et al., 2000; Durmic et al., 2002). Nevertheless, these findings could not be reproduced 
(Kirkwood et al., 2000) and contradict a recent studies according to which a diet with 
fermentable carbohydrates deriving from dried chicory roots and sweet lupines also protected 
animals from SD (Thomsen et al., 2007). High concentration of inulin in this diet could be 
responsible for this effect (Hansen et al., 2010; Hansen et al., 2011). Additionally, numbers of 
Bifidobacterium thermacidophilum and Megasphaera elsdenii were increased in the 
microbiota of animals fed with chicory roots and sweet lupines (M
lbak et al., 2007), but 
previously described changes in the gut flora (Leser et al., 2000) as a consequence of an 
infection with B. hyodysenteriae could not be observed. An indirect influence of diet due to 
changes in the composition of the intestinal microbial flora should be kept in mind, since in 
vitro B. hyodysenteriae could be inhibited by Lactobacillus spp., Bifidobacterium 
thermophilum, Enterococcus faecium and Bacillus subtilis (Bernardeau et al., 2009; Klose et 
al., 2009).  
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Furthermore, clinical outcome may be influenced by variations in virulence among 
B. hyodysenteriae strains (Kinyon et al., 1977; Hyatt et al., 1994; Thomson et al., 2001; La et 
al., 2011). However, the occurrence of avirulent strains must be taken with caution since 
taxonomical classifications are not completed and avirulent strains sometimes show atypical 
phenotypical and genetic features (Thomson et al., 2001). Great progress in virulence 
determination was achieved when genetic manipulation became possible. Cloning of 
haemolysin and flagellar genes of B. hyodysenteriae (Muir et al., 1992; Koopman et al., 
1992b) and gene transfer through electroporation and homologous recombination (ter Huurne 
et al., 1992) were the first successful attempts. Prior to that, biochemical investigations, in 
vitro assay with lysates as well as comparison of B. hyodysenteriae with apathogenic species 
were used for the description of virulence determinants. For a long time, the main criterion for 
distinguishing B. hyodysenteriae from apathogenic species was the strong beta-haemolysis. 
Therefore, haemolysins are considered to be one of the main virulence factors. The 
haemolysin is an oxygen-resistant, heat-labile protein with no lipolytic or proteolytic activity, 
and it is active within a broad range of pH values (Saheb et al., 1980a). Reported size varies 
from 19 kDa (Kent et al., 1988) to 74 kDa (Saheb et al., 1980a). Haemolysis activity is 
temperature-dependant (Saheb and Lafleure, 1980b). A cytotoxic effect on several eukaryotic 
cell lines (Muir et al., 1992) is observed, and enterocytes exposed to purified haemolysin 
developed lesions similar to those seen in SD (Lysons et al., 1992). Inactivation of a 
haemolysin gene by homologous recombination produced still haemolytic but less virulent 
mutants (ter Huurne et al., 1992). In further investigations three genes (tylA, tylB, tylC) were 
determined to be responsible for haemolysis (ter Huurne et al., 1994). TylB- and tylC-related 
genes are present in B. innocens (ter Huurne et al., 1994). However, protein sequences of 
purified beta-haemolysin did not correlate with the cloned gene sequences. Subsequently, a 
different haemolysin gene (hylA) was detected, cloned and expressed in Escherichia coli (Hsu 
et al., 2001). Hybridisation indicates that hylA is present in B. hyodysenteriae and 
B. intermedia but not in B. innocens. Regarding the virulence, tylA mutants showed a reduced 
virulence in pigs and had the potential to protect pigs against challenge with wild-type strains 
(Hyatt et al., 1994). The responsible immune response for the protection is yet unclear. Serum 
of convalescent pigs did not react in Western blot with recombinant haemolysin (Muir et al., 
1992). Even if animals infected with the mutant strain did not develop clinical signs, the 
shedding of B. hyodysenteriae was observed indicating that colonisation by the mutant strain 
is still possible (Hyatt et al., 1994). Nevertheless, in the same study different wild-type strains 
distinguished in their virulence regardless their haemolytic activity. Therefore, haemolysin 
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may be only one factor contributing to pathogenesis. Stanton and Cornell (1987) suggest 
erythrocytes as source for essential lipids for growth. Haemolysis of red blood cells may 
facilitate the supply of B. hyodysenteriae with nutrients. Additional important factors for the 
colonisation of the large intestine are chemotaxis and motility. A close association of 
B. hyodysenteriae with colonic mucosa is observed in electronic microscopy, while 
attachment and penetration or invasion of intact epithelium was not detected (Kennedy et al., 
1988). Mainly, B. hyodysenteriae was present in the mucus-filled crypts of Lieberkühn and 
the mucus gel covering the epithelium. Furthermore, B. hyodysenteriae was highly motile in 
intestinal mucus and chemotactic to porcine mucus and hog gastric mucus (Kennedy et al., 
1988; Milner and Sellwood, 1994). An attempt including different Brachyspira strains 
demonstrated that virulent strains of B. hyodysenteriae were more chemotactic than avirulent 
B. hyodysenteriae strains, B. pilosicoli, B. intermedia and B. innocens (Milner and Sellwood, 
1994). Genetic disruptions of flagellar genes (flaA1, flaA2, flaB1, flaB2, flaB3) led to 
reduced motility and velocity (Rosey et al., 1995; Rosey et al., 1996; Li et al., 2000) and 
reduced virulence and colonisation in mice (Rosey et al., 1995; Rosey et al., 1996). Similar 
results could be detected for nox-deleted mutants in swine. Fewer animals were colonised by 
the mutants and symptoms were less severe compared to the wild-type strain (Stanton et al., 
1999). A well characterized virulence factor in Gram-negative bacteria are 
lipopolysaccharides (LPS). LPS are components of the cell wall of Gram-negative bacteria, 
which are antigenic and play a major role as endotoxins in the pathogenesis of bacterial 
infections. Their release of bacterial cells activates the immune system. Cytokines such as 
tumour necrosis factor (TNF) and Interleukin-1 (IL-1) are produced, and inflammation up to 
septic shock can occur (Valentin-Weigand, 2011). In the case of B. hyodysenteriae, a specific 
antigen could be extracted by hot phenol-water extraction which was assumed to be an LPS 
(Baum and Joens, 1979) until the determination of the molecular weight revealed it to be a 
lipooligosaccharide (LOS) (Halter and Joens, 1988). In vitro, LOS of B. hyodysenteriae was 
toxic for murine peritoneal macrophages, increased the internalisation of erythrocytes 
mediated by complement and immunoglobulin G-Fc receptors, enhanced the migration of 
porcine leucocytes and stimulated proliferation of mouse splenocytes (Nuessen et al., 1982). 
Endotoxin preparations (butanol/water extraction) showed a stronger biological activity and 
induced IL-1, IL-6 and TNF production in mice and swine (Greer and Wannemuehler, 1989b; 
Nibbelink et al., 1997). However, the comparison of the biological activity of LOS and 
endotoxin extracted from B. hyodysenteriae and the apathogenic B. innocens did not provide 
indications for the different pathogenic potential (Greer and Wannemuehler, 1989a).  
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The influence of the host was studied with C3H/HeJ mouse strains, which are hyporesponsive 
to LPS and did not develop gross lesions in the intestine after experimental infection (Nuessen 
et al., 1983). Additionally, the injection of extracted LOS had no lethal effect. Gross lesions 
and lethality were seen in LPS-susceptible mouse strains. However, macrophages isolated 
from the C3H/HeJ mice were chemotactic to LOS (Nuessen et al., 1983). These findings 
could be confirmed by Nibbelink and Wannemuehler (1991), who observed different 
susceptibility to infection depending on the mouse strain. Therefore, host responsiveness to 
LPS may contribute to the pathogenesis. Broad access to molecular techniques opened new 
possibilities for virulence determination. Due to whole genome sequencing, a plasmid could 
be detected in B. hyodysenteriae WA1 (Bellgard et al., 2009) containing potential virulence 
genes. The plasmid was missing in a known avirulent strain and, after an investigation of 264 
Australian field isolates, another isolate without plasmid was detected and examined for 
virulence in experimental infection of pigs (La et al., 2011). Since it was less virulent than the 
control strain, the genes located on the plasmid may be involved in pathogenesis of SD. An 
examination of a German collection of Brachyspira spp. for different virulence-associated 
genes revealed high genetic heterogeneity, and no uniform pattern among B. hyodysenteriae 
could be detected (Barth et al., 2012). Conclusively, pathogenesis and virulence of 
Bhyodysenteriae are still not fully understood. All of the described factors reflect the 
adaptation of B. hyodysenteriae to its habitat and confirm the close association of virulence 
and lifestyle of the organism (Wassenaar and Gaastra, 2001).  
 
2.6 Diagnosis 
Due to the variation in the course of disease, only a presumptive diagnosis can be made based 
on clinical signs. Diarrhoea with blood and/or mucus is the most indicative symptom, but 
dehydration, depression and increase of temperature are observed as well. Haematological 
changes include increase of leucocytes, erythrocyte sedimentation and fibrinogen levels, left 
shift of neutrophils and significant electrolyte imbalances (Waldmann and Lindemann, 1990; 
Hampson et al., 2006). Besides, clinical handling includes farm history, evaluation of 
production form, biosecurity measurements and performance data. The immunity seen in pigs 
which recovered from infection prompted investigations of specific antibodies against 
B. hyodysenteriae and efforts for the development of serological tests. However, the 
diagnostic value of serological tests remains questionable, since serogroup specificity, in the 
case of LOS, and cross-reactivity between Brachyspira spp. are observed (Halter and Joens, 
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1988; Kent et al., 1989). Up to now, the only potential application of a serological test is the 
use of an indirect Enzyme-linked Immunosorbent Assay (ELISA) for the detection of SD on 
herd level (La et al., 2009; Song et al., 2012; Song et al., 2015).  
In necropsy, a diffuse fibrinous to mucohaemorrhagic enteritis with pseudomembrane is 
found located in the large intestine. Histopathological lesions are mucosal oedema, invasion 
of lymphocytes and neutrophils, dilated colonic crypts filled with mucus and superficial 
erosion (Glock and Harris, 1972; Hampson et al., 2006). Especially in acutely infected 
animals, numerous spirochaetal bacteria are present. However, for a definitive diagnosis of 
SD, B. hyodysenteriae must be proved in the faeces or colonic mucosa. Though culture is 
effortful and time-consuming, it is the most practiced method for the detection of 
B. hyodysenteriae. Faeces, rectal swabs with medium and mucosal scrapings from necropsy 
are suitable samples. Cultures are incubated at 37°C to 42°C in anaerobic atmosphere for up 
to seven days. Traditionally, a selective agar based on trypticase soy agar (TSA) 
supplemented with various antimicrobials is used for culture, but since there is no 
recommended standard method, a variety of selective agars is applied. Initially, TSA and 
spectinomycin (TSA-S400) for the inhibition of the faecal concomitant flora was developed 
(Songer et al., 1976). Kunkle and Kinyon (1988) added pig faeces extract and colistin, 
spiramycin, rifampicin and vancomycin (BJ-agar). The BJ-agar was modified to BJ-Actidion 
agar by the addition of cycloheximide to inhibit mycological contamination (Dünser et al., 
1997). Blood agar modified medium consisting of a blood agar base, defibrinated horse blood, 
beef extract and bacto peptone with spectinomycin and rifampin (BAM-SR) (Calderaro et al., 
2001) in combination with a pre-treatment in brain heart infusion broth with spectinomycin 
and rifampin (Calderaro et al., 2005) supported growth of B. hyodysenteriae within 48 h. The 
addition of colistin, spectinomycin, rifampicin and flavomycin to blood agar modified 
medium (BAM-CSRF) enhanced the recovery rate of B. hyodysenteriae, but pre-enrichment 
enhanced the occurrence of contaminating faecal flora (Lugsomya et al., 2012). Microscopical 
examinations can give a hint for spirochaetal growth, but further characterisation is required. 
Phenotypical tests based on biochemical features (Fellström and Gunnarsson., 1995) and 
serological detection of antigens were widely used before molecular methods became more 
accessible. By now, both methods are widely replaced by polymerase chain reaction (PCR) 
(Elder et al., 1994). Common target genes are the 23S rDNA, nox gene, tylA gene, (Leser et 
al., 1997; Atyeo et al., 1999; Fellström et al., 2001) and 16S rDNA for B. pilosicoli (Park et 
al., 1995; Fellström et al., 1997; Atyeo et al., 1998). Duplex PCRs detecting both swine 
pathogens B. hyodysenteriae and B. pilosicoli are described as well (La et al., 2003). 
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However, a PCR targeting tylA gene for B. hyodysenteriae and 16S rRNA gene for 
B. pilosicoli was less sensitive for B. hyodysenteriae than culture in combination with 
biochemical typing (Råsbäck et al., 2006). For the simultaneous detection of different 
pathogens like B. hyodysenteriae, Lawsonia intracellularis and Salmonella spp., multiplex 
PCRs are established (Suh and Song, 2005). Effectiveness of PCR could even be enhanced by 
establishing real-time PCR (Akase et al., 2009). An alternative method for further analysis of 
cultured Brachyspira is MALDI TOF (Calederaro et al., 2013; Prohaska et al., 2014), but 
mixed culture of different Brachyspira spp. cannot be unambiguously identified, which is the 
main disadvantage compared to PCR.  
 
2.7 Treatment 
Though certain immunity is seen in convalescent pigs, a commercial vaccination is not 
available, and disease control focusses on biosecurity and antimicrobial treatment. Biosecurity 
measurements include disinfection, limited access to production site, quarantine control of 
rodents and insects as well as fencing off wild boars. All-in-all-out production systems are 
recommended, and new pigs should be purchased from SD-free farms. However, in case of 
disease, the only therapy option is antimicrobial treatment. Unfortunately, there is only a 
limited selection of antimicrobial agents available for the treatment of SD. Drugs are applied 
in food or drinking water, but in severe cases, animals should be treated parenterally since 
water and food intake are reduced in sick animals. Mortality of SD mostly occurs due to 
dehydration. There are two treatment strategies. In herds with persisting SD, therapeutic 
success is defined by the reduction or elimination of clinical signs without stopping the 
colonisation by B. hyodysenteriae. A comparable effect may be achieved by good 
management. However, eradication always is the preferred option. Hereby, the elimination of 
the agent is the main objective of therapy, and additional measures like depopulation, vector 
control and disinfection of manure are incorporated (Neto, 2008; Speiser et al., 2011). Despite 
the central role of antimicrobial treatment in SD control, antimicrobial susceptibility testing 
(AST) is not standardised. In general, mainly two different methods for AST of Brachyspira 
are performed: agar dilution and broth dilution. All tests determine the minimal inhibitory 
concentration (MIC) for the antimicrobial agents. The MIC is defined as the lowest 
concentration of an antimicrobial agent that prevents visible growth of a microorganism 
(CLSI, Document VET01-A4, 2013). Agar dilution is the recommended method of AST of 
anaerobic bacteria (CLSI, Document M11-A8, 2012). Different concentrations of 
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antimicrobials are moulded in agar plates and examined for bacterial growth. However, the 
difficulty of testing Brachyspira with agar dilution is the detection of visible growth. 
Brachyspira are slow-growing bacteria and initial growth can only be detected by the 
appearance of haemolysis. However, subinhibitory concentrations of antimicrobial agents 
may prevent haemolysis (Shibl and Gemell, 1983). Besides, agar plates are produced 
manually, which is laborious and susceptible to faults, especially if low concentrations are 
required. For the broth dilution, liquid medium with decreasing concentrations of an 
antimicrobial agent is used instead of agar plates. Visible growth is defined by the appearance 
of turbidity. It can be differentiated between macro- and microdilution based on the size of the 
volume. Microdilution tests are usually performed in microtitre plates encoated with the 
antimicrobial agents. For Brachyspira, a commercial microdilution test is available.  
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3 Materials and Methods 
 
3.1 Isolates 
For the antimicrobial susceptibility testing, 30 B. hyodysenteriae porcine field isolates were 
tested. They were cultured during routine diagnostics from 2009 to 2015 from nine different 
Swiss cantons (Fig. 1). For isolation, faecal swabs from pigs were streaked on a selective agar 
(BSA), a modified BJ-Actidion agar without pig faeces extract and cyclohexidime (Dünser et 
al., 1997). Agar plates were checked for spirochaetal growth by native microscopy after 
incubation at 42°C in an anaerobic atmosphere of 80% N2, 10% CO2 and 10% O2 (Trilab, 
bioMérieux, Switzerland) for two to seven days. The temperature of 42°C is adjusted to 
inhibit concomitant intestinal flora. If samples were positive in native microscopy, they were 
subcultured on Columbia blood agar (Oxoid, Switzerland) for further molecular 
investigations. The PCR used in the diagnostic workflow is a duplex PCR for 
B. hyodysenteriae and B. pilosicoli (La et al., 2003) based on nox and 16S rRNA gene, 
respectively. Isolates were frozen in brain heart infusion (BHI) (Becton, Dickinson and 
Company, Switzerland) with glycerine (Sigma Aldrich, Switzerland) and foetal calve serum 
(Sigma Aldrich, Switzerland) at –80°C. Isolates were refrozen on Columbia blood agar 
(Oxoid, Switzerland) and checked by native microscopy for contaminations. Because of their 
swarming behaviour, cultures with more than one Brachyspira spp. are difficult to detect. In 
order to avoid mixed Brachyspira cultures, all isolates were tested for their purity by a real-
time PCR (Borgström et al., 2016) based on 23S rRNA gene. Finally, isolates could be used 
for further testing.  
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Figure 1: Map of Switzerland. B. hyodysenteriae isolates investigated in the study are sampled from 
the red-coloured cantons. 
 
 
3.2 Inoculum 
In order to obtain a precise inoculum for testing, cell counts of B. hyodysenteriae were set in 
proportion to the OD600 and a regression curve was developed. Therefore, B. hyodysenteriae 
ATCC reference strain was streaked on Columbia blood agar and incubated for three days at 
42°C and then suspended in 2ml NaCl 0.9%. A serial dilution of the suspension was done 
(1:2, 1:4, 1:8 and 1:16). The optical density of all dilutions was measured at a wavelength of 
600nm (BioPhotometer, eppendorf, Switzerland). Two times, 2 µl of the 1:8 dilution were 
transferred to an object slide, and ten visual fields of each were counted in a counting 
chamber at 400x magnification. The mean value was determined and was divided by 10 to 
obtain the mean value of spirochaetes per reticule (X), which was inserted into the following 
formula:  
X x 2592 x 1000 x 8 = number of spirochaetes per ml 
The volume under the coverslip is 2 µl, the area of the reticule fits 5184 times in the area of 
the coverslip. Therefore, the volume under the reticule is 0.000385802 µl. Hence, the number 
of spirochaetes has to be multiplied by 2592 to get the number of spirochaetes per µl and by 
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1000 to get the number of spirochaetes per ml. In order to take the dilution into account, a 
multiplication by 8 has to be done. Finally, the number of spirochaetes per ml is obtained. The 
optical density and the number of spirochaetes were set in proportion and a regression curve 
was created (Fig. 2).  
 
Figure 2: The regression curve shows the correlation between bacterial cell count (bacteria/ml) and 
the OD600. 
 
3.3 Antimicrobial Susceptibility Testing 
Antimicrobial susceptibility testing was performed with the VetMIC Brachy panel (Statens 
veterinärmedicinska anstalt, Sweden), a commercial broth microdilution test. The 
antimicrobial agents included in the test are the pleuromutilins tiamulin (0.063 µg/ml to 
8 µg/ml) and valnemulin (0.031 µg/ml to 4 µg/ml), the tetracycline doxycycline (0.125 µg/ml 
to 16 µg/ml), lincomycin (0.5 µg/ml to 64 µg/ml) as well as the macrolide tylosin (2 µg/ml to 
128 µg/ml) and its derivate tylvalosin/aivlosin (0.25 µg/ml to 32 µg/ml). The VetMIC Brachy 
panel consists of a 48-well plate coated with the six different antimicrobials in arithmetically 
decreasing concentrations. The inoculation of the VetMIC Brachy panel was performed with 
modifications to the manufacturer’s instructions and is described as follows: Isolates were 
streaked on Columbia blood agar and incubated at 42°C for three days. Cultures were 
harvested in brain heart infusion (Becton, Dickinson and Company, Switzerland) with 10% 
foetal calve serum (Sigma Aldrich, Switzerland) (BHI + FCS) until an optical density of 0.6 E 
to 0.8 E was reached. The suspension was diluted 1:1000 in BHI + FCS, corresponding to 2 to 
3 x 107 bacterial cells per ml. For confirmation, a microscopical cell count of 10 visual fields 
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at 100x magnification was made. Two VetMIC plates in parallel were inoculated with 500 µl 
per well. An additional control plate without antibiotics as growth control and a negative 
control with BHI + FCS only was incubated. The three plates were incubated in an anaerobic 
jar (AnaeroGen 2.5 l, Thermo Scientific, Switzerland) at 37°C and shook initially for four 
days. In order to detect contamination, cultures were examined by native microscopy and 
were streaked on Columbia blood agar (aerobic and anaerobic at 37°C) three times (before the 
incubation of the VetMIC plates, at the first evaluation after four days and at the second 
evaluation after seven days). After four days, all plates were evaluated macroscopically with a 
mirror for turbidity. For the first plate, the OD600 of all turbid wells and at least two of the 
proximate clear wells was measured, while the second plate was incubated for another three 
days. After seven days, the second plate was again evaluated macroscopically, and this time 
the measurement of OD600 of all turbid wells and at least two of the proximate clear wells was 
performed as well (Fig. 3). Therefore, four MIC values were obtained for every isolate. 
ATCC strain 27164 was tested in parallel at every approach and every field isolate was tested 
twice. 
Figure 3: The workflow of AST. Every isolate was tested four times in two approaches. Two plates 
per approach were tested under the same conditions and evaluated visually. For one plate, OD600 was 
additionally measured. The second plate was incubated and was evaluated after another three days of 
incubation. Controls were established before the testing, after four days and after seven days. 
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3.4 Sequencing 
All tested isolates were sequenced for a point mutation in the 23S rRNA gene responsible for 
lincosamide and macrolide resistance as previously published (Karlsson, 1999). For DNA 
extraction, bacteria were harvested from Columbia blood agar and suspended in molecular 
grade water (Milli-Q, Millipore Corporation). After a centrifugation for 1 min at 12,000 rpm, 
the supernatant was rejected and the remaining pellet was resuspended in 200 µl lysis buffer 
(Instagen Matrix, Bio-Rad). Samples were incubated and shaken at 56°C for 15–30 min and 
afterwards for 8 min at 99°C. After another centrifugation at 12,000 rpm for 3 min, 100 µl of 
the supernatant were used. DNA concentrations were determined spectrophotometrically 
(NANODROP 2000c, Thermo Scientific). The primers used for the PCR are previously 
described by Karlsson et al. (1999). The primer concentration was 20 uM and the DNA 
template used 20 ng/µl. The master mix used and the PCR cycle conditions are presented in 
Figure 4. The expected fragment of 388bp was presented by capillary electrophoresis 
(QIAxcel, QIAGEN, Switzerland). The DNA was purified with the QIAquick PCR 
Purification Kit (QIAGEN, Switzerland) in QIAcube (QIAGEN, Switzerland) according to 
the manufacturer’s protocol. The sequencing was performed externally by Microsynth AG 
(Switzerland). For the analysis of the obtained sequences, ApE (A Plasmid Editor) software 
was used.  
 
Figure 4: Master Mix and PCR cycle conditions used for the sequencing of the 23S rRNA gene. 
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3.5. Antimicrobial Activity 
The influence of the used medium (BHI + FCS), the atmosphere as well as the time of 
incubation on the activity of the antimicrobial agents was examined. Therefore, stock 
solutions of the six antimicrobials used in the testing were prepared. A concentration of 
5.12 mg/ml was set for the stock solution to facilitate the following dilutions. Taking the 
potency of the agents into account, 51.3 mg tiamulin (Tiamulin fumarate VETRANAL), 
52.8 mg valnemulin (Valnemulin-hydrochloride VETRANAL), 52.7 mg doxycycline 
(Doxycycline hyclate VETRANAL), 53.2 mg lincomycin (Lincomycin hydrochloride 
monohydrate VETRANAL) and 55.3 mg tylosin (Tylosin tartrate VETRANAL), respectively, 
were dissolved in 10 ml distilled water. The five aforementioned antimicrobial agents were all 
obtained from Sigma-Aldrich, Switzerland. For tylvalosin, 51 mg (Aivlosin/tylvalosin 
tartrate, EcoAnimal Health, United Kingdom) were solved in 5 ml ethanol (99%) and refilled 
with 5 ml distilled water.  
In order to evaluate if BHI + FCS influences the activity of the antimicrobial agents, it was 
compared with Müller Hinton (MH) broth (Oxoid, Switzerland), the standard medium for 
AST. Therefore, a microdilution with Staphylococcus aureus ATCC 29213, a reference strain 
for AST and susceptible to all tested antimicrobial agents, was performed. An inoculum of 
0.5 McFarland of Staphylococcus aureus ATCC 29213 was produced, diluted 1:100, and 
50 µl per well were distributed in a 96-well microtitre plate. The stock solution was diluted 
1:10 and a serial dilution from 256 µg/ml to 0.5 µg/ml was performed. Finally, every well 
contained 100 µl with 5 x 104 bacteria. This was done with BHI + FCS and MH broth. The 
test was incubated at 37°C between 17 h and 20 h. In order to examine the influence of 
atmosphere, plates were incubated aerobically and anaerobically. Furthermore, 
Staphylococcus aureus ATCC 29213 was tested with a VetMIC Brachy plate with 
BHI + FCS. The obtained MIC values were compared to each other and controlled with 
published MIC values of Staphylococcus aureus ATCC 29213 (Tab. 1). The influence of 
incubation time was evaluated as follows: BHI + FCS and MH broth, respectively, were 
incubated with the antimicrobial agents with the concentration of 512 µg/ml at 37°C 
aerobically and anaerobically for seven days altogether. Every 24 h an aliquot was taken off 
and frozen at –20°C. The aliquots were used as basis for the aforementioned serial dilution 
and tested against Staphylococcus aureus ATCC 29213. If antimicrobial agents were 
inactivated during this time, the concentration would decrease in every well and growth of 
Staphylococcus aureus ATCC 29213 would be detected in more wells.  
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Table 1: Quality range of Staphylococcus aureus ATCC 29213. MIC values obtained in our study by 
microbroth and VetMIC Brachy panel are compared to published MIC values.  
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4 Results 

4.1 Isolates 
The study included 30 Swiss B. hyodysenteriae isolates collected from 2009 to 2015. For an 
accurate AST, the purity of isolates must be ensured. However, the field isolates thawed from 
the collection had a high rate of contamination. Native microscopy as exclusive investigation 
to detect contamination was insufficient, and additional controls in form of aerobic and 
anaerobic cultures on Columbia blood agar were established. Besides contamination with 
non-spirochaetal bacteria, mixed cultures with different Brachyspira spp. were quite common 
and were detected by a real-time PCR (Borgström et al., 2016) to be excluded from the study. 
Since subcultivation of the impure isolates was time-consuming, contamination aggravated 
the AST enormously and was the main criterion for the disqualification from the study.  
 
4.2 Inoculum 
One object of the study was the optimisation and evaluation of the broth microdilution for 
routine diagnostics. First of all, a method to establish a precise inoculum based on cell 
counting rather than colony-forming units was developed. Therefore, a regression curve, 
which shows the correlation between optical density and bacterial cell counting, was 
developed (Fig. 2). Optical density and bacterial cell counts showed a good correlation, and 
an inoculum of 2 to 3 x 107 could be adjusted.  
 
4.3 Antimicrobial Activity 
Additionally, BHI + FCS was compared to MH broth, the standard medium for AST. When 
tested against a susceptible Staphylococcus aureus ATCC 29213, MICs obtained from the 
attempts with BHI + FCS were in the quality range of Staphylococcus aureus ATCC 29213 
(Tab. 1), and attempts with BHI + FCS did not differ more than one twofold dilution. Neither 
did the incubation at an anaerobic atmosphere influence the results of the AST of 
Staphylococcus aureus ATCC 29213. The MICs were the same when testing was performed 
under aerobic conditions. Besides, an inactivation of the antimicrobial agents over the time of 
seven days could not be observed.  
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4.4 Antimicrobial Susceptibility Testing 
4.4.1 Determination of Minimal Inhibitory Concentrations 
The antimicrobial susceptibility for Swiss B. hyodysenteriae isolates was determined and the 
MIC values which were obtained after four days of incubation are depicted in Figure 5. The 
MIC50 and MIC90 were calculated and are presented in Table 2. Visually detectable growth 
could be confirmed by OD600.  
The best susceptibility and a unimodal distribution of the isolates could be seen for the 
pleuromutilins (Fig. 5A/B). All isolates were inhibited at very low concentrations. Tiamulin 
had an MIC50 of 0.063 µg/ml and an MIC90 of 0.125 µg/ml. Both values were consistent in 
all four attempts. The MIC50 of valnemulin in the four attempts was 0.031 µg/ml. 
Differences of MIC90 could be seen between approach 1 and 2. The MIC90 for valnemulin in 
approach 1 was 0.031 µg/ml and 0.063 µg/ml in approach 2. For doxycycline, growth could 
be detected up to a concentration of 4 µg/ml with more isolates being inhibited at the lowest 
concentrations tested. The MIC50 of doxycycline was 0.25 µg/ml and MIC90 2 µg/ml (three 
out of four attempts) and 1 µg/ml in one of the attempts. The AST of lincomycin parted 
isolates into two populations. Between 30% and 37% of the isolates were inhibited at 
0.5 µg/ml. Three out of four attempts revealed an MIC50 of 16 µg/ml, whereas MIC50 was 
8 µg/ml in one attempt. In all testings an MIC90 of 32 µg/ml could be determined. The highest 
MIC values were detected for tylosin. The highest concentration tested (>128 µg/ml) could 
not inhibit growth for 50% to 60% of the isolates. Therefore, MIC50 and MIC90 of tylosin 
were identical at >128 µg/ml. Isolates with high MIC values also showed increased MIC 
values for lincomycin. The testing of tylvalosin revealed an MIC50 of 4 µg/ml and 2 µg/ml, 
respectively, and MIC90 was 8 µg/ml.  
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Figure 5: Distribution of MICs (in µg/ml) obtained from all plates after four days of incubation. The 
percentage of isolates showing skips are presented on the right-hand side, since an accurate MIC 
determination is not possible if skips occur.  
 
 
 
Table 2: MIC50 and MIC90 of all approaches after four and seven days, respectively.  
 
* MIC90 could not be determined after seven days in approach 2, since 17% of the isolates showed skips. 
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4.4.2 Reproducibility and Sequencing 
For evaluation of the reproducibility, every isolate was tested four times. The comparison of 
the four MICs obtained for the same isolates after four days of incubation revealed the 
following results: For the pleuromutilins and doxycycline the test showed a good 
reproducibility. Within an approach under the same conditions performed on the same day 
with the same inoculum, MIC values never differ more than onefold doubling dilution 
(Fig. 6A). The same could be applied for the pleuromutilins when the two approaches 
performed on different days were compared (Fig. 6B). For doxycycline, 23% of the isolates 
differed in MIC values two doubling dilution steps between the two approaches (Fig. 6B). 
Similar results were obtained by the parallel testing of B. hyodysenteriae ATCC 27164 for the 
pleuromutilins and doxycycline (Tab. 3). No deviation in MICs was observed for tiamulin. 
The range for valnemulin was 0.031 µg/ml to 0.063 µg/ml and for doxycycline 
0.125 µg/ml to 0.5 µg/ml. However, for lincomycin and the macrolides, between 3% and 
10% of the isolates within the same approach and 3% to 17% between the two approaches had 
MIC values differing more than two doubling dilutions (Fig. 6A/B). Besides, the control 
strain, which is originally inhibited at low concentrations of lincomycin and macrolides, grew 
in some approaches up to concentrations of 32 µg/ml (lincomycin), >128 µg/ml (tylosin) and 
8 µg/ml (tylvalosin), respectively (Tab. 3). The deviation of the isolates based on so-called 
skips, a phenomenon where growth is already inhibited but can again be detected in wells 
with higher antimicrobial concentrations (Fig. 7). The percentage of isolates showing skips 
are displayed in Figure 5. Skips only occurred for lincomycin and the macrolides and 
influenced the reproducibility of testing. Since mutation is a possible origin for skips, isolates 
were sequenced for point mutations in the 23S rRNA gene. For every isolate the 388bp 
fragment could be detected by PCR (Fig. 8A) Isolates with high lincomycin and macrolide 
MIC values had an A -> T conversion (Fig. 8B; Tab. 4). The lowest concentration observed in 
mutated isolates was 4 µg/ml for lincomycin, 8 µg/ml for tylosin and 1 µg/ml for tylvalosin. 
Skips could only be detected in wild-type isolates except for two mutated isolates (No. 23 and 
No. 684), which showed skips for tylvalosin (Tab. 4). In a further step, B. hyodysenteriae was 
subcultivated out of the isolated turbid wells with the higher antimicrobial concentration and 
sequenced for the mutation. Sequences from subcultivations from skipped wells revealed an 
A -> G conversion. The same conversion could be detected for the control strain with the 
increased MIC values for lincomycin and tylosin, where growth was detected up to a 
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concentration of >128 µg/ml for tylosin. Sequences from subcultivations out of wells with 
concentration of 8 µg/ml tylosin were either wild-type or mutated.  
Figure 6: Variance of MIC values after four days of incubation. Fig. 6A presents the variance within 
an approach and Fig. 6B the variance between approaches 1 and 2 performed on two different days. 
The red colour highlights the isolates which had the same MIC value in the different testings. The grey 
colour represents the deviation of one doubling dilution and the blue colour the deviation of two 
doubling dilutions. The green colour presents isolates differing more than two doubling dilution steps 
including isolates where skips occur. 
 
Table 3: Range of MIC values for B. hyodysenteriae ATCC 27164. The range of MIC values for 
B. hyodysenteriae ATCC 27164 obtained in our study is compared with the range of MIC values 
obtained in other studies. It is kept in mind that different testing methods influence the results.  
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Figure 7: Photography of a VetMIC Brachy plate with skipped wells for lincomycin and tylosin. The 
red-encircled wells show growth although growth is inhibited in the three previous wells with lower 
concentration of antimicrobial agent. Antimicrobial agents top down are: tiamulin, valnemulin, 
doxycycline, tylvalosin, lincomycin, and tylosin. 
 
Figure 8: Results of the sequencing of the 23S rRNA gene. Fig. 8A shows the 388bp fragment of the 
23S rRNA gene for 12 out of the 30 field isolates. An A -> T conversion could be detected in the 
sequence presented in Fig. 8B (red circle). 
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Table 4: Range of MIC values for lincomycin, tylosin and tylvalosin. Wild-type isolates (=wt) are 
highlighted in grey. Isolates with mutation showed an A -> T conversion. 
 
 
4.5 Incubation Time 
The evaluation after seven days revealed in 53 out of 60 approaches an increase of MIC 
values for at least one antimicrobial agent (Fig. 9). If an increase of MIC values occurred in 
the first approach, it was not inevitably seen in the second approach of the same isolate. An 
increase could be observed for all antimicrobial agents (Fig. 9). The deviation was the least 
for valnemulin, where 97% (approach 1) and 90% (approach 2) of the isolates had the same 
MIC value at day four and day seven (Fig. 10). The highest increase was seen for tylvalosin, 
where only 33% (approach 1) and 40% (approach 2) of the isolates did not differ in their MIC 
values after the three days of additional incubation. A shift towards higher MIC50 and MIC90 
was seen for doxycycline, lincomycin and tylvalosin (Tab. 2). However, time did not 
influence the antimicrobial activity of the agents, when tested against the susceptible 
Staphylococcus aureus ATCC 29213.  
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Figure 9.1: Evaluation of three days additional incubation of approach 1. Blue bars show the MIC 
values of the isolates after four days of incubation and orange bars the ones after seven days of 
incubation. A shift towards higher MIC values could be detected after seven days of incubation. The 
occurrence of skips is depicted at the right.  
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Figure 9.2: Evaluation of three days additional incubation of approach 2.  
 
Figure 10: Increase of the MIC values after three days additional incubation. Approach 1 is presented 
in Fig. 10A and approach 2 in Fig. 10B. The red colour highlights isolates which showed no increase 
of MIC values after seven days. Grey-coloured isolates showed an increase of the MIC values of one 
doubling dilution and blue two doubling dilutions. The green colour presents isolates with an increase 
of more than two doubling dilutions including isolates where skips occurred.                                                    
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5 Discussion 
 
5.1 Isolates 
The selection of isolates comprises a collection of samples from different farms located in 
nine Swiss cantons from 2009 to 2015. Concerning the period of time, the collection is 
representative for Switzerland because B. hyodysenteriae was first detected in 2008. 
However, in a geographical context, only parts of Switzerland are covered. Most of the 
isolates are obtained from the surveillance programme performed for the Swiss Pig Health 
Service. The membership in the Swiss Pig Health Service is voluntary, but participating farms 
are investigated for B. hyodysenteriae and B. pilosicoli twice a year. Therefore, the selection 
of isolates reflects where SD is investigated regularly. For unknown reasons, high 
contamination rates of the thawed isolates were observed. The swarming of B. hyodysenteriae 
aggravates the visual detection of contamination, and for further control native and darkfield 
microscopy, respectively, are widely used. In our study the sole use of native microscopy was 
not sufficient and supplementary controls had to be established. High contamination rates 
(42%) were also observed in a Swedish study with isolates from birds (Jansson et al., 2011). 
The authors assume that the contaminating bacteria adapt faster to the changing conditions 
after thawing and then overgrow the slow growing Brachyspira. Microscopical controls of 
culture before freezing is recommended. Filtration, which was used in the Swedish study to 
eliminate the contamination, was not successful in our study. Besides, the involvement of 
other anaerobic bacteria (Meyer et al., 1974; Whipp et al., 1979) in the pathogenesis of SD 
was presumed initially. Even though their role in pathogenesis could not be confirmed, they 
are able to aggravate clinical outcome. Co-infection may lead to co-culturing and finally to 
contamination. Bacterial interactions in vitro are only investigated for bacteria inhibiting the 
growth of B. hyodysenteriae (Bernadeau et al., 2009). Synergistic effects in culture have not 
been examined. Furthermore, antimicrobial resistance of Enterobacteriaceae is progressive, 
and the antimicrobials used in the selective agar for inhibition of concomitant flora may be 
ineffective (Lugsomya et al., 2012). The contaminating bacteria in our study were not further 
identified. The optimisation of culture is not in the focus of research anymore, and effective 
methods to clone Brachyspira is not yet developed, which aggravates accurate AST.  
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5.2 Inoculum 
Besides the purity of isolates, a precise inoculum is essential for AST and it can be 
determined with the help of two methods. The first one is based on viable cell counts in form 
of colony-forming units (CFU), which is recommended by the manufacturer of the VetMIC 
Brachy panel. The decision for CFUs was made because B. hyodysenteriae coil under 
suboptimal conditions and bacterial cell counting may include cells which are not viable 
anymore (Karlsson et al., 2003). However, B. hyodysenteriae does not form colonies under 
normal conditions, and methods inhibiting the swarming on agar plates may as well have 
inhibiting effects on growth. Therefore, we decided to use an inoculum based on bacterial cell 
counts. In order to avoid the counting of dead cells, only bacteria with the typical spirochaetal 
form were included. The development of the regression curve allowed a conclusion from the 
OD600 to the number of bacteria. Nevertheless, the measurement of OD is laborious and 
time-consuming and is not a suitable method for routine diagnostics. The influence of 
different inoculum sizes was not determined in our study. For agar dilution, an influence of 
inoculum size on MIC values of four reference strains was observed depending on the 
antimicrobial agent tested (Kitai et al., 1987). For the microdilution test, this could not be 
confirmed (Karlsson et al., 2003).  
 
5.3 Antimicrobial Activity 
The comparison with MH broth revealed BHI + FCS to be a suitable medium for the AST of 
B. hyodysenteriae. Deviations of the standard medium for fastidious bacteria are allowed, but 
the suitability of the medium must be proved (CLSI, Document M11-A8, 2012). The time of 
incubation did not influence the MIC values of Staphylococcus aureus ATCC 29213. 
However, an increase of MIC values after three days additional incubation could be seen for 
the B. hyodysenteriae field isolates, especially for tylvalosin. Since inactivation of the 
antimicrobial agents could be excluded, the reason for the increase is not known. 
 
5.4 Antimicrobial Susceptibility Testing  
 
The data for antimicrobial susceptibility obtained for the tested Swiss isolates reflect an 
agreeable situation in Switzerland compared to other European countries. Progressive 
resistance is observed in many countries, which is alarming regarding the limited selection of 
antimicrobial agents licensed for the treatment of SD (Novotná and Škardová, 2002; Rohde 
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et al., 2004; Šperling et al., 2011, Hidalgo et al., 2011). The admitted antimicrobial agents in 
Switzerland include tiamulin, valnemulin and lincomycin. There is no product available 
containing tylvalosin. Products containing tylosin and doxycycline are licensed for swine, but 
the treatment of SD is off-label and requires rededication. However, for a proper rededication 
of drugs, data of antimicrobial susceptibility are essential. This leads to the next difficulty 
concerning the AST of B. hyodysenteriae. There are no standardised clinical breakpoints for 
the correct interpretation of results. Interpretation has to be carried out based on two 
publications, which supply divergent breakpoints for the classification. The first one (Rønne 
and Szancer, 1990) delivers breakpoints for tiamulin, lincomycin and tylosin. The breakpoint 
determination is based on pharmacokinetics in pigs based on the ratio between MIC values 
obtained with agar dilution and concentrations of antimicrobials in colonic tissue or serum 
(Tab. 5). The second publication takes colonic content concentrations, MIC values and, if 
available, clinical data into account and provides breakpoints for tiamulin, valnemulin, 
lincomycin, tylosin and tylvalosin (Burch, 2005). Besides, the second study differentiates 
between the testing methods used, since agar dilution, at least for the pleuromutilins, leads in 
average to MIC values which are one dilution step lower than microbroth does (Rohde et al., 
2004). Furthermore, caution has to be taken with the interpretation of clinical studies because 
there are two therapeutic approaches. Therapeutic success can be defined as the reduction or 
elimination of clinical SD without stopping colonisation by B. hyodysenteriae, referring to 
herds which are persistently infected. However, the elimination of the agent is essential for 
eradication programmes and different treatment protocols are needed. Thus, interpretation of 
results becomes complex and ambiguous.  
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Table 5: Breakpoints for the classification. The breakpoints suggested by Rønne and Szancer (1990) 
are determined by agar dilution. The dosage of the antimicrobial agent is not specified. Isolates are 
classified in susceptible, intermediate and resistant for tiamulin, lincomycin and tylosin. Burch (2005) 
suggests breakpoints with the dosage of the antimicrobial agent for tiamulin, valnemulin, lincomycin, 
tylosin and tylvalosin determined by microbroth and agar dilution, respectively. 
 
 
 
Rønne and Szancer (1990) categorize isolates 1 µg/ml as susceptible and >4 µg/ml as 
resistant to tiamulin. In a study including the clinical efficacy of therapy (Vyt and Hommez, 
2006), the treatment with tiamulin was inefficient for isolates with MICs >1 µg/ml. This is in 
accordance with the investigation of 72 Swedish B. hyodysenteriae field isolates showing that 
the susceptible wild-type population had MIC values below 0.5 µg/ml (Karlsson et al., 2003). 
Thus, a lowering of the breakpoint to >0.5 µg/ml and >1 µg/ml, respectively, is postulated 
(Karlsson et al., 2003; Lobová et al., 2004; Vyt and Hommez, 2006). Since MIC values for 
pleuromutilins are in average one fold lower when tested in microbroth instead of agar 
dilution, Burch (2005) suggests a breakpoint of 0.5 µg/ml for isolates tested with microbroth 
and 1 µg/ml for isolates tested by agar dilution. All Swiss isolates tested in this study were 
susceptible to tiamulin irrespectively of the breakpoint used. The same applies to valnemulin 
with all isolates showing full susceptibility using the breakpoint of <0.125 µg/ml. High 
efficacy of pleuromutilins cannot be taken for granted since reduced susceptibility is quite 
common (Karlsson et al., 2002; Lobová et al., 2004; Molnàr, 1996; Rohde et al., 2004). In 
Spain, the treatment with pleuromutilins can be regarded as ineffective against one third of 
the isolates (Hidalgo et al., 2009). Furthermore, multiresistant isolates occur in Spain and 
Czech Republic (Šperling et al., 2011; Hidalgo et al., 2011). Progression of resistance can be 
presumed (Molnàr, 1996) and exacerbates the situation. In Sweden, a country comparable to 
Switzerland concerning the health status of pig herds and the use of antimicrobial drugs, a 
gradual increase of MIC values for tiamulin could be detected in the period between 1990 and 
2003 (Pringle et al., 2012). However, the increase stagnated, which the authors lead back to a 
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national eradication programme with a controlled use of tiamulin. Besides, the stagnation is in 
good agreement with the slow and stepwise development of resistance described for the 
pleuromutilins (Karlsson et al., 2001; Karlsson et al., 2004a; Lobovà et al., 2004), which is an 
indication for the involvement of several genes. Though mutations of the L3 and 23S rRNA 
gene leading to alterations of the ribosomal binding site were found in isolates with reduced 
pleuromutilin susceptibility (Pringle et al., 2004; Hidalgo et al., 2011; Hillen et al., 2014), the 
resistance mechanism is not fully understood. The pleuromutilins showed the best 
reproducibility in the test. Both antimicrobial agents never differed more than one twofold 
dilution within an approach and between the two approaches after the four day evaluation. 
The increase after three days additional incubation did not go beyond one twofold dilution 
step either. That could be applied for the field isolates and the control strain ATCC 27164. 
Since tiamulin and valnemulin are licensed for the treatment of SD, the reliable results are 
quite important. However, all isolates had very low MICs, and whether good reproducibility 
is stable for isolates with higher MIC values can only be presumed. In an interlaboratory 
study, a multiply resistant B. hyodysenteriae isolate failed as potential quality control strain 
for antimicrobial susceptibility testing by broth dilution (Pringle et al., 2006). 
For doxycycline, no breakpoints are available. In a genetic investigation of the bimodal 
population seen for German and Swedish field isolates, a point mutation of the 16S rRNA 
gene, correlating to a known tetracycline binding site in the 30S ribosomal subunit, could be 
detected (Pringle et al., 2007). Susceptible wild-type isolates had MICs from 0.125 µg/ml to 
0.25 µg/ml and the mutated isolates had MICs between 1 µg/ml and 4 µg/ml. This is in good 
accordance with the findings in our study and using the cut-off value of 1 µg/ml (Zmudszki 
et al., 2012), 20% of the Swiss isolates showed reduced susceptibility to doxycycline. The 
reproducibility for doxycycline was in an acceptable range. No deviation greater than two 
twofold dilutions was observed.  
Lincomycin is one of the admitted antimicrobial agents for Switzerland and therefore the 
antimicrobial susceptibility data are of special interest. About one third of the isolates could 
be inhibited at the lowest concentration (0.5 µg/ml). Then a gap with no isolates having the 
MICs of 1 µg/ml and 2 µg/ml occurs, and then growth could be detected up to concentrations 
of 32 µg/ml. Applying the breakpoint of 4 µg/ml (Rønne and Szancer, 1990), about one third 
of the isolates would be susceptible. The rest of the isolates could be comprised as 
intermediate (>4 µg/ml to 16 µg/ml). However, there are hints that in vitro testing is not in 
agreement with clinical outcome since therapy with lincomycin was successful in strains 
classified as resistant according to Rønne and Szancer (1990) (Smith, 1990; Vyt and 
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Hommez, 2006). Hence, Burch (2005) elevated the breakpoint to >50 µg/ml. Subsequently, 
lincomycin would be efficient against all tested isolates. The MIC values for tylosin of half of 
the isolates were higher than the range tested (>128 µg/ml). Consequently, 69% to 83% of the 
isolates are resistant according to Rønne and Szancer (1990). Some isolates cannot be 
categorized since the VetMIC Brachy panel does not include the breakpoint of 1 µg/ml for 
susceptible isolates. Between half and two thirds of the isolates are classified as resistant to 
tylosin applying the breakpoint of >16 µg/ml (Burch, 2005). The rest of the isolates could be 
categorized as susceptible. For tylvalosin, susceptibility of all isolates could be determined 
(Burch, 2005). The genetic base of lincomycin and tylosin resistance is well understood for 
B. hyodysenteriae. Because of the common binding site at the 50S ribosomal subunit, cross-
resistance between macrolides, lincosamides and streptogramins (MLSB-resistance) is usually 
observed (Vester and Douthwaite, 2001). In the case of B. hyodysenteriae, a point mutation of 
the 23S rDNA is described (Karlsson et al., 1999). The 30 isolates were sequenced for the 
occurrence of the point mutation. Wild-type isolates without a mutation in the 23S rDNA 
sequence showed great ranges for MICs and additionally skips in testing. Sequencing of 
populations isolated from separated turbid wells where skips occurred in testing could verify 
the existence of the mutation in original wild-type isolates. Wild-type isolates had MIC values 
up to concentrations of 4µg/ml, which correlates with the clinical breakpoints for intermediate 
isolates (Rønne and Szancer, 1990). Mutated isolates showed two different MIC distributions 
with one group having MICs >128 µg/ml and a few isolates with lower MICs from 8 to 
32 µg/ml. Two strains had a range of 8 to >128 µg/ml and 16 to >128 µg/ml, respectively. An 
explanation could be that there is another resistance mechanism that parts the strains into 
high-level resistance isolates and low-level resistance isolates. From a clinical perspective this 
subdivision becomes relevant if the breakpoints of Burch (2005) are applied. Isolates with 
MICs of 8 µg/ml and 16 µg/ml would be classified as susceptible although they have an 
acquired resistance mechanism in form of a mutation. The same is seen for lincomycin, where 
isolates with point mutation are comprised in the susceptible range. It is possible that clinical 
outcome is still effective, but then the resistance mechanism responsible for clinical resistance 
is not known. Consequently, a phenotypic classification must be performed. However, the 
reproducibility of the test for lincomycin and macrolides was strongly influenced by the 
occurrence of skips leading to unreliable results. The occurrence of skipped wells has been 
previously described for B. pilosicoli (Karlsson et al., 2004b; Mirajkar and Gebhart, 2016) but 
not for B. hyodysenteriae, yet. Since contamination in skipped wells could be excluded and 
manufacturing error is unlikely, mutation or tolerance of the isolates are the remaining 
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explanations for skips. As cloning of B. hyodysenteriae is not yet possible, more than one 
clone may be present in the inoculum, and if the amount of mutated clones is sufficient, 
growth can be detected in higher concentrations. However, in purely statistical terms, one 
would expect a continuous elevation of MIC values rather than skips like it was seen in the 
control strain because the ratio of mutated and non-mutated clones should be the same in 
every single well. The second explanation is that mutation may take place in wells with higher 
concentrations during incubation. The sequencing does not fully clarify the question. 
Subcultures of wells with low concentrations showed the wild-type genotype. No bacterial 
growth was yielded from subcultivations of clear wells between two turbid wells. Subcultured 
bacteria of the skipped wells with the higher antimicrobial concentration were mutated. 
Whether a pure clone is present or one clone is predominant cannot be clarified by 
sequencing. Karlsson et al. (2004b) assume that the lower genetic stability of B. pilosicoli is 
responsible for the occurrence of skips and concludes that the microdilution test is less 
suitable for B. pilosicoli. However, susceptible B. hyodysenteriae strains became resistant in 
vitro after subculture on agar containing 4 µg/ml tylosin (Karlsson et al., 1999), and the 
reverse effect of a resistant strain becoming susceptible again could be observed as well (Kitai 
e al., 1987). Time and again, unusual phenomena are seen in AST of bacteria. The 
paradoxical effect defines the increase of surviving bacterial cells proportional to 
concentrations higher than the minimal bactericidal concentration (Eagle, 1948). It is best 
described for Staphylococcus aureus and -lactam antimicrobials, but the paradox occurs for 
different bacterial species and antimicrobial classes (Amsterdam, 1996). In our case, skips 
were seen sporadically at different concentrations and were not reproducible. Hence, the 
occurrence of skips is not a paradoxical effect in the strict sense.  
In conclusion, the evaluation of antimicrobial susceptibility of B. hyodysenteriae isolates from 
Switzerland was overdue, broth microdilution gave an overview of the Swiss situation, and 
trends towards lower susceptibility are detectable. However, the precise determination of 
MICs has to be treated with caution, and an accurate classification of isolates into susceptible 
and resistant isolates is challenging due to the lack of unambiguous pharmacological data. 
Furthermore, comparisons between studies are difficult since methods and interpretations are 
not uniform. AST of B. hyodysenteriae is still methodically immature and further 
standardisations must be established.  
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